These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3279381)

  • 21. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes.
    Mínguez Mínguez F; Lima JE; García MT; Prieto J
    Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of clinical isolates of Fusarium to antifungal drugs.
    Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C
    Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The postantibiotic effect of antifungal agents against common pathogenic yeasts.
    Turnidge JD; Gudmundsson S; Vogelman B; Craig WA
    J Antimicrob Chemother; 1994 Jul; 34(1):83-92. PubMed ID: 7961219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.
    Espinel-Ingroff A; Abreu DPB; Almeida-Paes R; Brilhante RSN; Chakrabarti A; Chowdhary A; Hagen F; Córdoba S; Gonzalez GM; Govender NP; Guarro J; Johnson EM; Kidd SE; Pereira SA; Rodrigues AM; Rozental S; Szeszs MW; Ballesté Alaniz R; Bonifaz A; Bonfietti LX; Borba-Santos LP; Capilla J; Colombo AL; Dolande M; Isla MG; Melhem MSC; Mesa-Arango AC; Oliveira MME; Panizo MM; Pires de Camargo Z; Zancope-Oliveira RM; Meis JF; Turnidge J
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi.
    Gonçalves SS; Stchigel AM; Cano J; Guarro J; Colombo AL
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1944-7. PubMed ID: 23335742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M; de Montclos H; Flandrois JP
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
    Vivas JR; Torres-Rodríguez JM
    Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of inoculum form on in vitro antifungal susceptibilities of Aspergillus spp.
    Pujol I; Fernández-Ballart J; Guarro J
    J Antimicrob Chemother; 2001 May; 47(5):715-8. PubMed ID: 11328793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal activity of the allylamine derivative terbinafine in vitro.
    Petranyi G; Meingassner JG; Mieth H
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1365-8. PubMed ID: 3674847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
    Rodriguez-Tudela JL; Martinez-Suárez JV
    J Antimicrob Chemother; 1995 Jun; 35(6):739-49. PubMed ID: 7559186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
    Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
    Batura-Gabryel H; Wieczorek U; Mlynarczyk W
    Pneumonol Alergol Pol; 1997; 65(5-6):355-9. PubMed ID: 9340063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models.
    Te Dorsthorst DT; Verweij PE; Meis JF; Punt NC; Mouton JW
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2007-13. PubMed ID: 15155192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
    Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
    Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro studies with SF 86-327, a new orally active allylamine derivative.
    Shadomy S; Espinel-Ingroff A; Gebhart RJ
    Sabouraudia; 1985 Apr; 23(2):125-32. PubMed ID: 2990057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic study of antifungal activity of amphotericin B, 5-fluorocytosine and ketoconazole against clinical yeast isolates using liquid-phase turbidimetry.
    Dei-Cas E; Dujardin L; Ribeiro Pinto ME; Ajana F; Fruit J; Poulain D; Camus D; Vernes A
    Mycoses; 1991; 34(3-4):167-72. PubMed ID: 1749396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Aspergillus activities of plant essential oils and their combination effects with ketoconazole or amphotericin B.
    Shin S
    Arch Pharm Res; 2003 May; 26(5):389-93. PubMed ID: 12785735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL; Monroy E; Negrete E; Vaca S
    Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.
    Vaezi A; Fakhim H; Arastehfar A; Shokohi T; Hedayati MT; Khodavaisy S; Rezaei-Matehkolaei A; Badiee P; Hagen F; Lass-Flörl C; Dannaoui E; Meis JF; Badali H
    Mycoses; 2018 Feb; 61(2):134-142. PubMed ID: 29064123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model.
    Singh SM; Sharma S; Chatterjee PK
    Mycopathologia; 1990 Dec; 112(3):127-37. PubMed ID: 2089254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.